Melanoma is the most lethal skin cancer, accounting for 2% of all skin cancer types, yet approximately 75% of skin cancer deaths. It often evolves from clear skin or existing moles, making it difficult to diagnose at early stage. Besides, the treatment of melanoma is a complex decision making process, which is affected by a large number of internal and external factors, e.g. disease location, staging, etc.